Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6788 | 1443 | 39.0 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
14 | 4 | ORTHOPEDICS//DENTISTRY, ORAL SURGERY & MEDICINE//SPORT SCIENCES | 808941 |
32 | 3 | OSTEOPOROSIS//VITAMIN D//OSTEOPOROSIS INTERNATIONAL | 107093 |
21 | 2 | OSTEOPOROSIS//OSTEOPOROSIS INTERNATIONAL//BONE MINERAL DENSITY | 36347 |
6788 | 1 | GLUCOCORTICOID INDUCED OSTEOPOROSIS//DEFLAZACORT//CORTICOSTEROID INDUCED OSTEOPOROSIS | 1443 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GLUCOCORTICOID INDUCED OSTEOPOROSIS | authKW | 967595 | 5% | 61% | 75 |
2 | DEFLAZACORT | authKW | 417957 | 3% | 45% | 44 |
3 | CORTICOSTEROID INDUCED OSTEOPOROSIS | authKW | 274215 | 1% | 72% | 18 |
4 | GLUCOCORTICOIDS | authKW | 247327 | 22% | 4% | 318 |
5 | OSTEOPOROSIS | authKW | 130311 | 24% | 2% | 345 |
6 | STEROID INDUCED OSTEOPOROSIS | authKW | 69243 | 0% | 55% | 6 |
7 | SYMPTOMATIC VERTEBRAL FRACTURE | authKW | 63478 | 0% | 100% | 3 |
8 | CALCITONIN LIKE ACTION | authKW | 42319 | 0% | 100% | 2 |
9 | EBM STUDY GRP ADVERSE EFFECTS CORTICOSTEROID THER | address | 42319 | 0% | 100% | 2 |
10 | MINIMALLY INVAS ORTHOPED SURG | address | 42319 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 13802 | 38% | 0% | 546 |
2 | Rheumatology | 13216 | 18% | 0% | 253 |
3 | Medicine, General & Internal | 724 | 12% | 0% | 170 |
4 | Medicine, Research & Experimental | 186 | 5% | 0% | 78 |
5 | Urology & Nephrology | 99 | 3% | 0% | 46 |
6 | Pharmacology & Pharmacy | 82 | 7% | 0% | 103 |
7 | Pediatrics | 71 | 3% | 0% | 50 |
8 | Respiratory System | 54 | 2% | 0% | 32 |
9 | Orthopedics | 48 | 2% | 0% | 32 |
10 | Allergy | 46 | 1% | 0% | 15 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EBM STUDY GRP ADVERSE EFFECTS CORTICOSTEROID THER | 42319 | 0% | 100% | 2 |
2 | MINIMALLY INVAS ORTHOPED SURG | 42319 | 0% | 100% | 2 |
3 | RHEUMATOL CLIN IMMUNOL F02223 | 42319 | 0% | 100% | 2 |
4 | OSTEOPOROSIS METAB BONE DIS | 33385 | 1% | 9% | 17 |
5 | CNR BIOMORPHOL FUNCT SCI | 28211 | 0% | 67% | 2 |
6 | BONE PROGRAM | 23687 | 1% | 10% | 11 |
7 | ABT INNERE MED RHEUMATOL OSTEOL | 21159 | 0% | 100% | 1 |
8 | ABT STOFFWECHSEL OSTEOL | 21159 | 0% | 100% | 1 |
9 | ADRENAL STEROID | 21159 | 0% | 100% | 1 |
10 | AETNA INTEGRATED INFORMAT | 21159 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CALCIFIED TISSUE INTERNATIONAL | 27322 | 5% | 2% | 79 |
2 | OSTEOPOROSIS INTERNATIONAL | 20444 | 5% | 1% | 69 |
3 | JOURNAL OF BONE AND MINERAL RESEARCH | 8883 | 4% | 1% | 53 |
4 | BONE | 8550 | 4% | 1% | 52 |
5 | FRONTIERS OF HORMONE RESEARCH | 5732 | 1% | 2% | 11 |
6 | JOURNAL OF BONE AND MINERAL METABOLISM | 3300 | 1% | 1% | 15 |
7 | JOURNAL OF RHEUMATOLOGY | 2733 | 3% | 0% | 41 |
8 | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2368 | 2% | 0% | 25 |
9 | ARTHRITIS AND RHEUMATISM | 1460 | 2% | 0% | 27 |
10 | ENDOCRINOLOGY | 1373 | 3% | 0% | 41 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLUCOCORTICOID INDUCED OSTEOPOROSIS | 967595 | 5% | 61% | 75 | Search GLUCOCORTICOID+INDUCED+OSTEOPOROSIS | Search GLUCOCORTICOID+INDUCED+OSTEOPOROSIS |
2 | DEFLAZACORT | 417957 | 3% | 45% | 44 | Search DEFLAZACORT | Search DEFLAZACORT |
3 | CORTICOSTEROID INDUCED OSTEOPOROSIS | 274215 | 1% | 72% | 18 | Search CORTICOSTEROID+INDUCED+OSTEOPOROSIS | Search CORTICOSTEROID+INDUCED+OSTEOPOROSIS |
4 | GLUCOCORTICOIDS | 247327 | 22% | 4% | 318 | Search GLUCOCORTICOIDS | Search GLUCOCORTICOIDS |
5 | OSTEOPOROSIS | 130311 | 24% | 2% | 345 | Search OSTEOPOROSIS | Search OSTEOPOROSIS |
6 | STEROID INDUCED OSTEOPOROSIS | 69243 | 0% | 55% | 6 | Search STEROID+INDUCED+OSTEOPOROSIS | Search STEROID+INDUCED+OSTEOPOROSIS |
7 | SYMPTOMATIC VERTEBRAL FRACTURE | 63478 | 0% | 100% | 3 | Search SYMPTOMATIC+VERTEBRAL+FRACTURE | Search SYMPTOMATIC+VERTEBRAL+FRACTURE |
8 | CALCITONIN LIKE ACTION | 42319 | 0% | 100% | 2 | Search CALCITONIN+LIKE+ACTION | Search CALCITONIN+LIKE+ACTION |
9 | PLAIN VITAMIN D | 42319 | 0% | 100% | 2 | Search PLAIN+VITAMIN+D | Search PLAIN+VITAMIN+D |
10 | BISPHOSPHONATES | 41873 | 7% | 2% | 98 | Search BISPHOSPHONATES | Search BISPHOSPHONATES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KENANIDIS, E , POTOUPNIS, ME , KAKOULIDIS, P , LEONIDOU, A , SAKELLARIOU, GT , SAYEGH, FE , TSIRIDIS, E , (2015) MANAGEMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS: CLINICAL DATA IN RELATION TO DISEASE DEMOGRAPHICS, BONE MINERAL DENSITY AND FRACTURE RISK.EXPERT OPINION ON DRUG SAFETY. VOL. 14. ISSUE 7. P. 1035 -1053 | 122 | 77% | 0 |
2 | GROSSMAN, JM , GORDON, R , RANGANATH, VK , DEAL, C , CAPLAN, L , CHEN, WL , CURTIS, JR , FURST, DE , MCMAHON, M , PATKAR, NM , ET AL (2010) AMERICAN COLLEGE OF RHEUMATOLOGY 2010 RECOMMENDATIONS FOR THE PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS.ARTHRITIS CARE & RESEARCH. VOL. 62. ISSUE 11. P. 1515 -1526 | 57 | 63% | 280 |
3 | RIZZOLI, R , BIVER, E , (2015) GLUCOCORTICOID-INDUCED OSTEOPOROSIS: WHO TO TREAT WITH WHAT AGENT?.NATURE REVIEWS RHEUMATOLOGY. VOL. 11. ISSUE 2. P. 98 -109 | 67 | 66% | 13 |
4 | SAAG, KG , (2003) GLUCOCORTICOID-INDUCED OSTEOPOROSIS.ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. VOL. 32. ISSUE 1. P. 135-+ | 99 | 62% | 76 |
5 | RIZZOLI, R , ADACHI, JD , COOPER, C , DERE, W , DEVOGELAER, JP , DIEZ-PEREZ, A , KANIS, JA , LASLOP, A , MITLAK, B , PAPAPOULOS, S , ET AL (2012) MANAGEMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS.CALCIFIED TISSUE INTERNATIONAL. VOL. 91. ISSUE 4. P. 225 -243 | 70 | 64% | 25 |
6 | DEVOGELAER, JP , (2006) GLUCORTICOID-INDUCED OSTEOPOROSIS: MECHANISMS AND THERAPEUTIC APPROACH.RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. VOL. 32. ISSUE 4. P. 733-+ | 84 | 67% | 10 |
7 | CLARKE, BL , (2012) CORTICOSTEROID-INDUCED OSTEOPOROSIS AN UPDATE FOR DERMATOLOGISTS.AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. VOL. 13. ISSUE 3. P. 167 -190 | 81 | 56% | 4 |
8 | LEKAMWASAM, S , ADACHI, JD , AGNUSDEI, D , BILEZIKIAN, J , BOONEN, S , BORGSTROM, F , COOPER, C , PEREZ, AD , EASTELL, R , HOFBAUER, LC , ET AL (2012) A FRAMEWORK FOR THE DEVELOPMENT OF GUIDELINES FOR THE MANAGEMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS.OSTEOPOROSIS INTERNATIONAL. VOL. 23. ISSUE 9. P. 2257-2276 | 72 | 48% | 74 |
9 | ADACHI, JD , PAPAIOANNOU, A , (2001) CORTICOSTEROID-INDUCED OSTEOPOROSIS - DETECTION AND MANAGEMENT.DRUG SAFETY. VOL. 24. ISSUE 8. P. 607 -624 | 83 | 72% | 11 |
10 | SHAKER, JL , LUKERT, BP , (2005) OSTEOPOROSIS ASSOCIATED WITH EXCESS GLUCOCORTICOIDS.ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. VOL. 34. ISSUE 2. P. 341-+ | 67 | 72% | 49 |
Classes with closest relation at Level 1 |